Similar articles for PMID: 29516410

Year	Number of Results
1981	1
1988	1
1989	1
2000	1
2003	3
2004	2
2005	3
2006	2
2007	6
2008	3
2009	3
2010	2
2011	5
2012	8
2013	6
2014	11
2015	10
2016	16
2017	10
2018	11
2019	10
2020	12
2021	11
2022	9
2023	7
2024	0

1

Adalimumab Reduces Extraintestinal Manifestations in Patients with Crohn's Disease: A Pooled Analysis of 11 Clinical Studies.

Louis EJ, Reinisch W, Schwartz DA, Löfberg R, Robinson AM, Berg S, Wang AW, Maa JF, Huang B, Pappalardo B. Louis EJ, et al. Adv Ther. 2018 Apr;35(4):563-576. doi: 10.1007/s12325-018-0678-0. Epub 2018 Mar 7. Adv Ther. 2018. PMID: 29516410 Free PMC article.

2

Efficacy of adalimumab for the treatment of extraintestinal manifestations of Crohn's disease.

Barreiro-de-Acosta M, Lorenzo A, Domínguez-Muñoz JE. Barreiro-de-Acosta M, et al. Rev Esp Enferm Dig. 2012 Sep;104(9):468-72. doi: 10.4321/s1130-01082012000900004. Rev Esp Enferm Dig. 2012. PMID: 23130854 Free article. Clinical Trial.

3

Impact of vedolizumab therapy on extra-intestinal manifestations in patients with inflammatory bowel disease: a multicentre cohort study nested in the OBSERV-IBD cohort.

Tadbiri S, Peyrin-Biroulet L, Serrero M, Filippi J, Pariente B, Roblin X, Buisson A, Stefanescu C, Trang-Poisson C, Altwegg R, Marteau P, Vaysse T, Bourrier A, Nancey S, Laharie D, Allez M, Savoye G, Gilletta C, Gagniere C, Vuitton L, Viennot S, Aubourg A, Pelletier AL, Bouguen G, Abitbol V, Fumery M, Claudepierre P, Bouhnik Y, Amiot A; GETAID OBSERV-IBD study group. Tadbiri S, et al. Aliment Pharmacol Ther. 2018 Feb;47(4):485-493. doi: 10.1111/apt.14419. Epub 2017 Dec 18. Aliment Pharmacol Ther. 2018. PMID: 29250803

4

The impact of ustekinumab on extraintestinal manifestations of Crohn's disease: A post hoc analysis of the UNITI studies.

Narula N, Aruljothy A, Wong ECL, Homenauth R, Alshahrani AA, Marshall JK, Reinisch W. Narula N, et al. United European Gastroenterol J. 2021 Jun;9(5):581-589. doi: 10.1002/ueg2.12094. Epub 2021 Jun 2. United European Gastroenterol J. 2021. PMID: 34077627 Free PMC article. Clinical Trial.

5

Extraintestinal manifestations of inflammatory bowel disease and the influence of smoking.

Roberts H, Rai SN, Pan J, Rao JM, Keskey RC, Kanaan Z, Short EP, Mottern E, Galandiuk S. Roberts H, et al. Digestion. 2014;90(2):122-9. doi: 10.1159/000363228. Epub 2014 Oct 1. Digestion. 2014. PMID: 25277851

6

Adalimumab produces clinical remission and reduces extraintestinal manifestations in Crohn's disease: results from CARE.

Löfberg R, Louis EV, Reinisch W, Robinson AM, Kron M, Camez A, Pollack PF. Löfberg R, et al. Inflamm Bowel Dis. 2012 Jan;18(1):1-9. doi: 10.1002/ibd.21663. Epub 2011 Feb 23. Inflamm Bowel Dis. 2012. PMID: 21351211 Clinical Trial.

7

The appearance of joint manifestations in the Swiss inflammatory bowel disease cohort.

Hiller A, Biedermann L, Fournier N, Butter M, Vavricka SR, Ciurea A, Rogler G, Scharl M; Swiss IBD Cohort Study Group. Hiller A, et al. PLoS One. 2019 Apr 30;14(4):e0211554. doi: 10.1371/journal.pone.0211554. eCollection 2019. PLoS One. 2019. PMID: 31039159 Free PMC article.

8

Infliximab in the treatment of extra-intestinal manifestations of Crohn's disease.

Rispo A, Scarpa R, Di Girolamo E, Cozzolino A, Lembo G, Atteno M, De Falco T, Lo Presti M, Castiglione F. Rispo A, et al. Scand J Rheumatol. 2005 Sep-Oct;34(5):387-91. doi: 10.1080/03009740510026698. Scand J Rheumatol. 2005. PMID: 16234187 Clinical Trial.

9

The impact of colectomy on the course of extraintestinal manifestations in Swiss inflammatory bowel disease cohort study patients.

Roth R, Vavricka S, Scharl M, Schreiner P, Safroneeva E, Greuter T, Zeitz J, Misselwitz B, Schoepfer A, Barry MP, Rogler G, Biedermann L; Swiss IBD cohort study. Roth R, et al. United European Gastroenterol J. 2021 Sep;9(7):773-780. doi: 10.1002/ueg2.12125. Epub 2021 Aug 25. United European Gastroenterol J. 2021. PMID: 34431613 Free PMC article.

10

Extraintestinal manifestations in Crohn's disease and ulcerative colitis: results from a prospective, population-based European inception cohort.

Isene R, Bernklev T, Høie O, Munkholm P, Tsianos E, Stockbrügger R, Odes S, Palm Ø, Småstuen M, Moum B; EC-IBD Study Group. Isene R, et al. Scand J Gastroenterol. 2015 Mar;50(3):300-5. doi: 10.3109/00365521.2014.991752. Epub 2014 Dec 23. Scand J Gastroenterol. 2015. PMID: 25535653

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

129 results

Results by year